Tag Archives: chief-executive

Executive Team | www.extropy.com

Posted: October 1, 2016 at 1:48 am

Nicholas Montera – Chief Executive Officer (CEO) and Managing Partner

Nicholas is one of the founding members of Extropy and is a leading information technology expert with extensive experience involving large-scale IT initiatives. In his role as CEO Nicholas has developed Extropys strategic approach and focused its efforts to provide world class professional services and solutions. His vision is for Extropy to recruit and cultivate the best talent in the industry expanding Extropys “tribal knowledge” base to deliver innovative solutions founded in deep experience and due diligence. As the Chief Executive Officer of Extropy, he provides leadership to the executive management team; ensuring that the company is focused on the mission and our actions are in alignment with our core values. Nicholas has been deeply involved throughout his career in information technology planning, sales and engagement management. He came to form Extropy after successful careers with both British Telecom and Avaya. Nicholas attended the Florida Institute of Technology studying Mechanical Engineering and Business Administration. He also holds the industries highest networking certification, Cisco Certified Internetworking Expert, (CCIE #11811).

Brett Coover – Chief Technology Officer (CTO) and Managing Partner

Brett is one of the founding members of Extropy and is a thought leader in solutions across many technologies and industries. As CTO Brett focuses Extropys “tribal knowledge” to define and refine our technology and business solutions; always staying ahead of the curve. His vision is centered on creating and delivering the most innovative technology solutions available and developing them into long term growth opportunities. Brett has extensive experience in delivering innovative solutions to Fortune 500 customers, transforming their businesses as a trusted partner. Additionally Brett has experience in developing and operating service provider organizations. Brett’s educational experience spans across the sciences, having attended Clarkson and the University of Buffalo studying physics, information and computer sciences. He also holds numerous certifications, including the industries highest networking certification, Cisco Certified Internetworking Expert, (CCIE #11918), and the most respected security certification, Certified Information Systems Security Professional (CISSP).

Do you know anyone at Extropy ?

Go here to read the rest:

Executive Team | http://www.extropy.com

Posted in Extropy | Comments Off on Executive Team | www.extropy.com

American Institute of Alternative Medicine

Posted: July 31, 2016 at 5:48 am

Diane Sater-Wee, BS LMT Chief Executive Officer

Diane is responsible for AIAM’s strategic direction and compliance with legal and accrediting standards. She has served on the National and State of Ohio Boards of the American Massage Therapy Association (AMTA), the Executive Committee for the National Council of Colleges of Acupuncture and Oriental Medicine, the founding board of the Ohio Council of Massage Therapy Schools, and on various committees for the State Medical Board of Ohio and the Asian Bodywork Therapy Association.

Diane worked as an Account Representative for five years and as an Engineer for another five years with IBM. Diane received her undergraduate degree from The Ohio State University College of Engineering and her massage diploma from the Central Ohio School of Massage. email

Helen co-founded AIAM with Diane in 1990. She is responsible for setting the schools administrative and financial objectives, policies and practices. She also directs the acquisition, development, implementation and operation support systems. In addition to her work at AIAM, Helen serves on the Accreditation Commission for Acupuncture and Oriental Medicine (ACAOM) site visit team for the evaluation of acupuncture schools across the country.

Helen serves on the Stonewall Columbus Board of Trustees and is on the Board of Directors for State of the Arts Productions. She previously served as President of the Pacific Association of Women Martial Artists. Helen has competed in both national and international martial arts competitions throughout her career and was an alternate in the 1988 Olympics. She competed on the U.S. Tae Kwon Do team in 1990, earning a silver medal in the World Cup in Madrid, Spain. Helen was inducted into the Bruce Lee Martial Arts Hall of Fame in 2015. email

Read the rest here:

American Institute of Alternative Medicine

Posted in Alternative Medicine | Comments Off on American Institute of Alternative Medicine

Technology News | Reuters.com

Posted: March 27, 2016 at 12:44 am

Verizon Communications Inc said an attacker had exploited a security vulnerability on its enterprise client portal to steal contact information of a number of customers.

26 Mar 2016

NEW YORK Apple Inc said the U.S. Justice Department’s new attempts to unlock an iPhone used by one of the San Bernardino shooters without the tech giant’s help could eliminate the government’s need for its assistance in a similar dispute in New York.

BOAO, China Ride hailing app company Uber Technologies Inc [UBER.UL] is generating more than $1 billion in profit a year in its top 30 cities globally, and partly using that money to bankroll its expansion in China, Chief Executive Travis Kalanick said in an interview.

25 Mar 2016

SHANGHAI China’s commerce ministry said on Friday it hoped telecom equipment maker ZTE Corp could be removed as soon as possible from a U.S. list of companies slapped with tough export restrictions this month.

24 Mar 2016

Netflix Inc said it had been lowering the quality of its video for customers watching its service on wireless networks such as AT&T and Verizon Communications for more than five years, The Wall Street Journal reported on Thursday.

24 Mar 2016

View original post here:

Technology News | Reuters.com

Posted in Technology | Comments Off on Technology News | Reuters.com

Space Foundation Statement on President's Proposed NASA Budget

Posted: February 3, 2015 at 6:49 pm

Washington, D.C.,(Feb. 2, 2015) — The Space Foundation today said it supports President Obama’s FY2016 budget request for the National Aeronautics and Space Administration (NASA). That request, released today, calls for a FY2016 top line budget of $18.5 billion for the nation’s space agency — a $519 million increase over what Congress approved for the current fiscal year.

“The President’s request is a move in the right direction,” said Space Foundation Chief Executive Officer Elliot Pulham.

“The U.S. investment in NASA is a strategic investment in the future — one that fuels our technology base, our global economic competitiveness, and our ability to lead international partnerships,” Pulham said.”In that context, we believe the NASA budget can, and should, continue to grow.The President’s FY2016 budget request preserves International Space Station operations through 2024, increases NASA science programs by $43 million to $5.29 billion, keeps the SLS-Orion program on track to provide capabilities for human exploration beyond low earth orbit, and preserves a space technology budget of $724.8 million.

“The proposed budget also includes a credible aeronautics program, funded at $571.4 million,” Pulham said, “and, very importantly, it keeps commercial crew transport programs on track with $1.2 billion in funding toward a competitive, two-supplier system that will return America to human spaceflight operations in just two years’ time.”

About the Space Foundation Founded in 1983, the Space Foundation is the foremost advocate for all sectors of space, and is a global, nonprofit leader in space awareness activities, educational programs and major industry events, including the annualSpace Symposium, in support of its mission “to advance space-related endeavors to inspire, enable and propel humanity.” Space Foundation World Headquarters in Colorado Springs, Colo., USA, has a publicDiscovery Center, includingEl Pomar Space Gallery,Northrop Grumman Science Center featuring Science On a Sphere and the Lockheed Martin Space Education Center.The Space Foundation has a field office in Houston, and conducts government affairs from its Washington, D.C., office.It annually publishesThe Space Report: The Authoritative Guide to Global Space Activity,andthrough itsSpace CertificationandSpace Technology Hall of Fame programs,recognizes space-basedinnovations that have been adapted to improve life on Earth. Visitwww.SpaceFoundation.org, follow us onFacebook,Instagram,LinkedIn,Pinterest,TwitterandYouTube,and read our e-newsletterSpace Watch.

# # #

Please follow SpaceRef on Twitter and Like us on Facebook.

Continued here:
Space Foundation Statement on President's Proposed NASA Budget

Posted in Space Station | Comments Off on Space Foundation Statement on President's Proposed NASA Budget

23andMe Gives Pfizer DNA Data as Startup Seeks Growth

Posted: January 12, 2015 at 8:48 pm

Jan. 12 (Bloomberg) — 23andMe Director of Business Development Emily Drabant Conley discusses her companys collaboration with Pfizer to help find new targets to treat disease and to design clinical trials. She speaks on “Bloomberg West.” (Source: Bloomberg)

23andMe Inc., the genetic-testing startup backed by Google Inc. (GOOG), is sharing DNA data on about 650,000 individuals with Pfizer Inc. (PFE), to help find new targets to treat disease and to design clinical trials.

The collaboration with Pfizer is the broadest announced so far in 23andMes ambitious plan to become a repository for humanitys genetic makeup, and to turn data gathered from $99 saliva tests sold to consumers into multimillion-dollar deals with drugmakers.

The agreement unveiled today gives the U.S.s largest drugmaker access to anonymous, aggregated information from consumers who bought 23andMes test over the past seven years to learn about their own genetic histories. It includes only people who agreed to let their data be used in research. Pfizer and 23andMe declined to give the deals value.

Related: 23andme Aims to End FDA Standoff This Year After Public Shaming

The Silicon Valley startup, named for the 23 pairs of chromosomes in human cells, is betting its growing troves of genetic data will prove essential to drug companies, medical researchers and even health and wellness companies.

Even as it seeks to expand its consumer tests around the world, the company is repairing relations with the U.S. Food and Drug Administration. An agency ruling in late 2013 left 23andMe unable to sell health analyses from the saliva tests.

Anne Wojcicki, co-founder and chief executive officer of 23andMe Inc., speaks during a Bloomberg Television interview in San Francisco, California, on Oct. 9, 2014. Close

Anne Wojcicki, co-founder and chief executive officer of 23andMe Inc., speaks during a… Read More

Close

See more here:
23andMe Gives Pfizer DNA Data as Startup Seeks Growth

Posted in DNA | Comments Off on 23andMe Gives Pfizer DNA Data as Startup Seeks Growth

Personal Genome Diagnostics, Inc. And Human Longevity, Inc …

Posted: at 8:47 pm

BALTIMORE and LA JOLLA, Calif., Jan. 12, 2015 /PRNewswire/ –Personal Genome Diagnostics, Inc. (PGDx), a provider of advanced cancer genome analysis and testing services, and Human Longevity, Inc. (HLI), the human health information technology and health care company, today announced that HLI will have access to PGDx’s cancer genomics solutions to expand its analysis of cancer genomes, including CancerSelect, PlasmaSelect, CancerXome, METDetect and CancerComplete. HLI has also licensed the PGDx Enterprise Solution platform, which is a turnkey solution that enables laboratories to conduct their own advanced cancer genomic testing using next-generation sequencing.

PGDx co-founder and Chief Medical Officer Luis Diaz, MD, noted, “As pioneers in the field of cancer genomics, we are delighted to be collaborating with HLI, a visionary company co-founded by genomics legend J. Craig Venter.” PGDx co-founder and Chief Scientific Officer Victor Velculescu, MD, PhD, added, “HLI’s commitment to changing the way medicine is practiced by systematically harnessing genomics data to address aging-associated diseases aligns well with our goal of transforming the treatment of cancer by enabling researchers, physicians and patients to use genomics data to advance and personalize cancer therapy.”

PGDx applies its advanced genomic methods to identify and characterize the unique genomic alterations in tumors using tissue and liquid biopsies from cancer patients. The ES platform utilizes PGDx’s proprietary bioinformatics software pipeline that provides industry-leading sensitivity and specificity, while maximizing accuracy in detecting multiple types of tumor-specific mutations. PGDx’s targeted gene panels focus on well-characterized genes that have been selected for their high biologic importance in cancer and their relevance to drug targets and pathways.

HLI is building the world’s largest and most comprehensive database of human genomic and phenotype data. The company has signed agreements with academic medical centers and large biotechnology companies to sequence and analyze human genomes, including those of cancer patients, to determine more precise treatments and more details about the specific tumor and cancer in that patient. The PGDx suite of solutions will enable even greater precision and detail for HLI’s customers and their patients.

As part of the agreement, HLI will perform sequencing and analysis for select PGDx customers and for their own research activities.

“Having access to PGDx’s capabilities, targeted cancer panels and Enterprise Solution platform for advanced cancer genomic testing is another important component to our already comprehensive and accurate database of human biological data,” said J. Craig Venter, PhD, HLI’s Co-founder, Chairman, and Chief Executive Officer. “We are excited to be partnering with PGDx and the extensive cancer genomics expertise and technology innovations developed by the world-class research team at PGDx.”

About Personal Genome DiagnosticsPersonal Genome Diagnostics (PGDx) provides advanced cancer genome analyses to oncologyresearchers, drug developers, clinicians and patients. The company uses advanced genomic methods and its deep expertise in cancer biology to identify and characterize the unique genomic alterations in tumors. PGDx’s proprietary methods for genome sequencing and analysis are complemented by its extensive experience in cancer genomics and clinical oncology. Co-founders Luis Diaz, MD, and Victor Velculescu, MD, PhD, are internationally recognized leaders in cancer genomics who have extensive experience in the practical application of advanced genomic technologies to research, drug development and clinical practice. PGDx’s CLIA-certified facility provides personalized cancer genome analyses to patients and their physicians. For more information, visit http://www.personalgenome.com.

About Human Longevity, Inc.HLI, a privately held company headquartered in San Diego, CA was founded in 2013 by pioneers in the fields of genomics and stem cell therapy. Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building the world’s most comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging related disease and human biological decline. HLI will be licensing access to its database, and developing new diagnostics and therapeutics as part of their product offerings. For more information please visitwww.humanlongevity.com

Contacts

PGDx Corporate: Antony Newton Chief Commercial Officer 443-602-8833 anewton@personalgenome.com

More:
Personal Genome Diagnostics, Inc. And Human Longevity, Inc …

Posted in Human Longevity | Comments Off on Personal Genome Diagnostics, Inc. And Human Longevity, Inc …

Personal Genome Diagnostics, Inc. And Human Longevity, Inc. Sign Cancer Genomics Agreement

Posted: at 8:47 pm

BALTIMORE and LA JOLLA, Calif., Jan. 12, 2015 /PRNewswire/ –Personal Genome Diagnostics, Inc. (PGDx), a provider of advanced cancer genome analysis and testing services, and Human Longevity, Inc. (HLI), the human health information technology and health care company, today announced that HLI will have access to PGDx’s cancer genomics solutions to expand its analysis of cancer genomes, including CancerSelect, PlasmaSelect, CancerXome, METDetect and CancerComplete. HLI has also licensed the PGDx Enterprise Solution platform, which is a turnkey solution that enables laboratories to conduct their own advanced cancer genomic testing using next-generation sequencing.

PGDx co-founder and Chief Medical Officer Luis Diaz, MD, noted, “As pioneers in the field of cancer genomics, we are delighted to be collaborating with HLI, a visionary company co-founded by genomics legend J. Craig Venter.” PGDx co-founder and Chief Scientific Officer Victor Velculescu, MD, PhD, added, “HLI’s commitment to changing the way medicine is practiced by systematically harnessing genomics data to address aging-associated diseases aligns well with our goal of transforming the treatment of cancer by enabling researchers, physicians and patients to use genomics data to advance and personalize cancer therapy.”

PGDx applies its advanced genomic methods to identify and characterize the unique genomic alterations in tumors using tissue and liquid biopsies from cancer patients. The ES platform utilizes PGDx’s proprietary bioinformatics software pipeline that provides industry-leading sensitivity and specificity, while maximizing accuracy in detecting multiple types of tumor-specific mutations. PGDx’s targeted gene panels focus on well-characterized genes that have been selected for their high biologic importance in cancer and their relevance to drug targets and pathways.

HLI is building the world’s largest and most comprehensive database of human genomic and phenotype data. The company has signed agreements with academic medical centers and large biotechnology companies to sequence and analyze human genomes, including those of cancer patients, to determine more precise treatments and more details about the specific tumor and cancer in that patient. The PGDx suite of solutions will enable even greater precision and detail for HLI’s customers and their patients.

As part of the agreement, HLI will perform sequencing and analysis for select PGDx customers and for their own research activities.

“Having access to PGDx’s capabilities, targeted cancer panels and Enterprise Solution platform for advanced cancer genomic testing is another important component to our already comprehensive and accurate database of human biological data,” said J. Craig Venter, PhD, HLI’s Co-founder, Chairman, and Chief Executive Officer. “We are excited to be partnering with PGDx and the extensive cancer genomics expertise and technology innovations developed by the world-class research team at PGDx.”

About Personal Genome DiagnosticsPersonal Genome Diagnostics (PGDx) provides advanced cancer genome analyses to oncologyresearchers, drug developers, clinicians and patients. The company uses advanced genomic methods and its deep expertise in cancer biology to identify and characterize the unique genomic alterations in tumors. PGDx’s proprietary methods for genome sequencing and analysis are complemented by its extensive experience in cancer genomics and clinical oncology. Co-founders Luis Diaz, MD, and Victor Velculescu, MD, PhD, are internationally recognized leaders in cancer genomics who have extensive experience in the practical application of advanced genomic technologies to research, drug development and clinical practice. PGDx’s CLIA-certified facility provides personalized cancer genome analyses to patients and their physicians. For more information, visit http://www.personalgenome.com.

About Human Longevity, Inc.HLI, a privately held company headquartered in San Diego, CA was founded in 2013 by pioneers in the fields of genomics and stem cell therapy. Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building the world’s most comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging related disease and human biological decline. HLI will be licensing access to its database, and developing new diagnostics and therapeutics as part of their product offerings. For more information please visitwww.humanlongevity.com

Contacts

PGDx Corporate: Antony Newton Chief Commercial Officer 443-602-8833 anewton@personalgenome.com

See the original post:
Personal Genome Diagnostics, Inc. And Human Longevity, Inc. Sign Cancer Genomics Agreement

Posted in Human Longevity | Comments Off on Personal Genome Diagnostics, Inc. And Human Longevity, Inc. Sign Cancer Genomics Agreement

'Close but no cigar': SpaceX reland fails

Posted: January 10, 2015 at 2:45 pm

An unmanned Space Exploration Technologies mission blasted off on Saturday carrying cargo for the International Space Station, but efforts to reland the rocket on a sea platform failed, the firm said.

“Rocket made it to drone spaceport ship, but landed hard. Close, but no cigar this time,” Elon Musk, founder and chief executive of SpaceX, as the company is called, said on Twitter.

Read MoreDisruptors 2015: SpaceX

“Bodes well for the future,” he added.

The Dragon cargo capsule itself was successfully launched into space and is expected to dock with the space station on Monday.

Seeking to cut the cost of space launches, SpaceX hoped to bring the rocket back to Earth, aiming to land it on a floating platform in the Atlantic Ocean some 200 miles (322 km) off Jacksonville, Fla., north of the Cape Canaveral Air Force Station launch site.

A ship stationed near the platform tried to capture the touchdown on video, but it was too dark and foggy, Musk said.

Engineers will look to work out what went wrong by studying data relayed during the descent, as well as pieces of the rocket itself, he added.

“Ship itself is fine. Some of the support equipment on the deck will need to be replaced,” said Musk, who prior to the launch had put the odds of a successful touchdown on the first attempt at just 50 percent.

The primary purpose of Saturday’s mission was to deliver cargo to the space station, a $100-billion laboratory that flies about 260 miles (418 km) above Earth.

See more here:
'Close but no cigar': SpaceX reland fails

Posted in Space Station | Comments Off on 'Close but no cigar': SpaceX reland fails

NATO Secretary General with President of Afghanistan and Chief Executive, 01 DEC 2014 – Video

Posted: December 4, 2014 at 8:52 pm



NATO Secretary General with President of Afghanistan and Chief Executive, 01 DEC 2014
Joint press point with NATO Secretary General Jens Stoltenberg, President of the Islamic Republic of Afghanistan Mohammad Ashraf Ghani and the Chief Executive Abdullah Abdullah. Held at NATO…

By: NATO

See the original post here:
NATO Secretary General with President of Afghanistan and Chief Executive, 01 DEC 2014 – Video

Posted in NATO | Comments Off on NATO Secretary General with President of Afghanistan and Chief Executive, 01 DEC 2014 – Video

Bitcoin: Sink or swim?

Posted: at 8:49 pm

Updated: 2014-12-04 07:05 By Deng Yanzi in Hong Kong(HK Edition)

Editor’s note: We continue with our innovation series this week on exciting pioneering firms in the Pearl River Delta region, with the launch of BitMEX, a derivatives trading platform dedicated to users of the virtual currency, bitcoin.

Bitcoin has been on a rollercoaster ride since 2013. While the extreme volatility of the digital currency may make many flinch, some bitcoin holders seek ways to hedge the risk,while speculators seek an opportunity to profit from the seesawing value.

A newly launched derivatives exchange platform, Bitcoin Mercantile Exchange (BitMEX), aims to meet both those needs.

Arthur Hayes, co-founder and chief executive officer of BitMEX, says he modeled the platform on existing derivatives exchanges for fiat currency.

Traders can deposit bitcoin from their wallet into their BitMEX account, and use them as margin to buy and sell futures contracts, with 0.005 percent trading fee on a completed transaction.

BitMEX won the Hong Kong leg of the Slush startup pitching competition in October, advancing to the main Slush event in Helsinki, Finland, last month. However, it failed to win a place in the Nov 18-19 worldwide contest.

According to Hayes, the present fee pool for bitcoin derivatives is $120 million a year. He expects the market to grow to half a billion US dollars in the next five to seven years, and even bigger when bitcoin becomes globally recognized and gains higher worth.

The value of bitcoin has been extremely volatile, starting at less than 0.1 US cent and skyrocketing in 2013, peaking at approximately $1,240 that November before falling precipitously. The current value of bitcoin hovers around $360, a plunge of more than 60 percent since the start of the year.

See the rest here:
Bitcoin: Sink or swim?

Posted in Bitcoin | Comments Off on Bitcoin: Sink or swim?